-
-
call us
+91-9888163636
Choosing the right products is one of the most important decisions when starting a gynaecology PCD pharma franchise business in India. From iron and folic acid supplements to fertility-related formulations, hormonal medicines, and vaginal-care products, different categories serve different healthcare needs.
For franchise partners, the objective is to identify products that are relevant to their local market, supported by appropriate product documentation, and available through a reliable pharmaceutical supplier.
Some gynae product categories worth evaluating for a PCD pharma franchise business include iron and folic acid supplements, pregnancy nutrition, PCOS-related formulations, progesterone products, menstrual-health medicines, fertility-related products, and selected vaginal and urinary healthcare products. Actual demand varies by location, prescribing practices, competition, and product availability.
Moruf Lifesciences offers a broad gynaecology and women's healthcare portfolio that includes products across these categories. This guide explores the product segments to consider and highlights examples from the company's published catalogue.
Iron and folic acid products are important categories to evaluate in a gynaecology-focused pharmaceutical portfolio. Healthcare professionals may recommend appropriate formulations in pregnancy care and for managing nutritional deficiencies, depending on individual requirements.
A franchise partner can assess this category by comparing product compositions, dosage forms, pricing, availability, and local market needs.
Corafer-FB: Ferrous bisglycinate, zinc bisglycinate, folic acid, and methylcobalamin.
Corafer-XT: Ferrous ascorbate, folic acid, and zinc sulphate.
Corafer-FG: An iron, folic acid, vitamin B12, and zinc formulation available as a syrup.
Corafer-AG: Ferrous asparto glycinate, L-methylfolate, and mecobalamin.
Folzin-5: Folic acid 5 mg.
Folzin-10: Folic acid 10 mg.
Why consider this category?
Iron and folic acid preparations are relevant to several women's healthcare settings. However, formulations are not interchangeable, and their use depends on clinical requirements. Franchise partners should verify each product's current composition and approved information before promoting it.
Pregnancy care is another category to consider when evaluating a gynae product portfolio. Depending on individual nutritional requirements, healthcare professionals may recommend supplements containing folate, iron, calcium, vitamin D, DHA, or other nutrients.
A portfolio with different formulations allows distributors to evaluate products according to their intended use and local requirements.
Wobest-P: A nutritional formulation containing DHA, calcium, vitamins, and minerals.
Folziate-D: Methylcobalamin, L-methylfolate, pyridoxal-5-phosphate, DHA, and vitamin D3.
Calmof-C: Coral calcium and vitamin D3.
Calmof-XT: A combination containing calcium, vitamin D3, methylcobalamin, L-methylfolate, and pyridoxal-5-phosphate.
Doxfa: Doxylamine succinate, folic acid, and pyridoxine hydrochloride.
Doxfa-OD: An enteric-coated formulation containing doxylamine succinate, folic acid, and pyridoxine hydrochloride.
These products serve different purposes and should be assessed individually. For example, a medicine containing doxylamine and pyridoxine should not be treated as equivalent to a general nutritional supplement.
Business consideration: When comparing pregnancy-care products, examine the formulation, dosage form, packaging, product documentation, and commercial terms rather than choosing solely by product count.
PCOS-related healthcare is an important segment to examine when selecting a gynaecology product portfolio. The category includes different types of medicines and nutritional formulations, and treatment depends on the patient's clinical needs.
Moruf Lifesciences lists several products associated with this segment.
Ferjoy-PCO: Myo-inositol, D-chiro-inositol, chromium, metformin hydrochloride, L-methylfolate calcium, and mecobalamin.
Ferjoy-IN: Myo-inositol, D-chiro-inositol, chromium, and vitamin D3.
Ferjoy-MF: Myo-inositol and metformin hydrochloride.
Ferjoy-ACE: Myo-inositol, D-chiro-inositol, L-methylfolate calcium, N-acetylcysteine, chromium, and vitamin D3.
Ferjoy-BD: A formulation listed with berberine hydrochloride, myo-inositol, D-chiro-inositol, and other ingredients.
Myletro 2.5 and Myletro 5: Letrozole formulations listed in different strengths.
These products should not be considered interchangeable. In particular, products containing prescription medicines require appropriate professional assessment and prescribing.
Why evaluate this category?
A distributor may find it useful to assess a range of products addressing different aspects of reproductive healthcare. The commercial suitability of each product depends on local requirements, approved indications, competition, availability, and the supplier's terms.
Hormonal medicines form another substantial category within gynaecology. Depending on the medicine and the clinical indication, they may be used in different reproductive-health contexts under medical supervision.
A franchise partner should pay particular attention to strengths, dosage forms, approved indications, storage requirements, and applicable prescription rules.
Mopreg 100 Injection: Natural micronised progesterone 100 mg.
Mopreg 200 Injection: Natural micronised progesterone 200 mg.
Mopreg-200: Natural micronised progesterone softgel capsules.
Mopreg-300 SR: Natural micronised progesterone sustained-release formulation.
Mopreg-400: Natural micronised progesterone 400 mg.
Mopreg Gel: Progesterone 8% gel.
Mytermcare-10: Dydrogesterone 10 mg.
Mytermcare 20 SR: Dydrogesterone 20 mg sustained-release tablets.
Mytermcare-30: Dydrogesterone 30 mg sustained-release tablets.
Estowar: Estradiol valerate 2 mg.
Estowar-H: Estradiol hemihydrate 2 mg.
The catalogue includes multiple strengths and dosage forms. Distributors should confirm the current product details directly with the company because the composition and presentation of individual listings may change.
Business consideration: A hormonal product range should be evaluated on documentation, supply reliability, storage and handling requirements, and the suitability of its products for the intended market.
Fertility and reproductive healthcare include several distinct product groups. These can include prescription medicines and nutritional formulations, each with specific indications and precautions.
Moruf Lifesciences lists the following examples.
Mofert-25: Clomifene citrate 25 mg.
Mofert-50: Clomifene citrate 50 mg.
Mofert 100: Clomifene 100 mg.
Mofert-UB: Clomiphene citrate with ubidecarenone.
Myletro 2.5: Letrozole 2.5 mg.
Myletro 5: Letrozole 5 mg.
Myber-0.5: Cabergoline 0.5 mg.
Ferjoy-M: A multi-ingredient formulation containing coenzyme Q10, astaxanthin, zinc, L-carnitine, lycopene, glutathione, selenium, and vitamin C.
Ferjoy-Q10: A formulation containing coenzyme Q10 and other listed ingredients.
Fertility medicines such as clomifene and letrozole require appropriate medical supervision. Their presence in a franchise portfolio should not be interpreted as a recommendation for unsupervised use.
What should franchise partners assess?
Compare the available formulations, relevant documentation, product availability, and commercial conditions. Do not assume that every product in this category will have equal demand or suit every market.
Menstrual-health products are another category worth reviewing when selecting products for a gynaecology franchise.
Healthcare professionals may use different medicines depending on the cause of heavy bleeding, painful periods, or menstrual irregularities. The appropriate treatment varies by diagnosis and patient circumstances.
Nexic-M: Tranexamic acid and mefenamic acid tablets.
Nexic-E: Tranexamic acid and etamsylate tablets.
Nexic-500: Tranexamic acid 500 mg.
Nexic Injection: Tranexamic acid injection.
Drowar-M: Drotaverine 80 mg and mefenamic acid 250 mg.
Drowar 80 Tablets: Drotaverine 80 mg.
Renorth-5: Norethisterone tablets.
Renorth-10 CR: Norethisterone 10 mg.
Renorth-15 CR: Norethisterone acetate 15 mg controlled-release tablets.
These medicines have different indications and precautions. Product selection and use should follow the relevant approved information and professional guidance.
For a franchise business, compare the available strengths, dosage forms, product documentation, and distribution requirements before deciding which products fit the local market.
Vaginal-care and selected anti-infective products are additional categories to examine within a specialised gynaecology portfolio.
The range may include products for specific vaginal conditions, but different formulations have different indications. They should not be marketed as interchangeable treatments.
Tinwar-CL-100: A vaginal formulation containing clindamycin 100 mg and clotrimazole 100 mg.
Tinwar-CL-200: A vaginal formulation containing clindamycin 100 mg and clotrimazole 200 mg.
Fentirest Cream: Fenticonazole 2%.
Morwise Kit: A combination listed with fluconazole, azithromycin, and secnidazole.
Wojoy Vaginal Wash: A lactic-acid-based vaginal wash containing sea buckthorn and tea tree oil among its listed ingredients.
The catalogue also includes other anti-infective products. Their current compositions, approved indications, and prescription requirements should be confirmed from official documentation.
Business consideration: When evaluating this segment, prioritise product documentation, appropriate labelling, supply conditions, and compliance with applicable regulations. Avoid unsupported claims about preventing or treating infections.
Urinary healthcare is another product category represented in Moruf Lifesciences' catalogue.
The company lists products containing cranberry extract, D-mannose, and citrate salts, as well as selected pharmaceutical products used for urinary conditions.
Morflow Syrup: Cranberry, D-mannose, and potassium-magnesium citrate.
Morflow Sachet: A formulation listed with cranberry extract, D-mannose, and potassium-magnesium citrate.
Morflow Tablet: Cranberry and D-mannose.
Nitmor-100 SR: Nitrofurantoin 100 mg sustained-release tablets.
Fosruf: Fosfomycin tromethamine oral powder.
These products have different compositions and uses. Nutritional or other non-antibiotic products should not be presented as substitutes for antibiotics when antibiotic treatment is clinically indicated.
For franchise partners, this category may be worth evaluating alongside the company's broader women's healthcare portfolio. Product availability and demand should be assessed for the intended territory.
There is no universal list of the most profitable or fastest-selling gynae products. Demand varies by location, healthcare requirements, competition, product availability, and prescribing practices.
A practical starting point is to compare the following categories:
| Product Category | Examples from Moruf Lifesciences | What to Evaluate |
|---|---|---|
| Iron and folic acid | Corafer-FB, Corafer-XT, Folzin-5 | Formulation, pricing, availability, and local requirements |
| Pregnancy nutrition | Wobest-P, Folziate-D, Calmof-C | Product composition, dosage form, and relevant market needs |
| PCOS-related products | Ferjoy-PCO, Ferjoy-IN, Ferjoy-MF | Product documentation, indications, and local demand |
| Progesterone formulations | Mopreg range, Mytermcare range | Strengths, dosage forms, storage, and prescription requirements |
| Fertility-related products | Mofert range, Myletro range | Approved indications, documentation, and supply |
| Menstrual health | Nexic-M, Nexic-E, Renorth range | Product details, local requirements, and competition |
| Vaginal healthcare | Tinwar-CL range, Fentirest Cream, Wojoy Vaginal Wash | Indications, product documentation, and regulatory requirements |
| Urinary healthcare | Morflow range, Nitmor-100 SR, Fosruf | Formulation, approved uses, and market suitability |
This comparison is a product-category guide, not a sales ranking. The products listed are examples from Moruf Lifesciences' published catalogue; current availability should be confirmed directly.
Product selection is only one part of building a pharmaceutical franchise business. The supplier's documentation, commercial terms, and ability to meet orders are equally important.
Review the current catalogue and identify products relevant to the intended market. Confirm the composition, strength, dosage form, packaging, and approved indications for each product.
Request applicable licences, product approvals, and manufacturing and quality documents. Verify that the documents are current and cover the relevant products, facilities, and activities.
Ask for the current price list, minimum order requirements, taxes, shipping costs, payment terms, and other applicable expenses. Calculate the working capital required rather than relying on advertised profit margins.
If the company offers monopoly-based franchise rights, confirm the exact territory, products covered, duration, conditions, and renewal terms in writing.
Discuss stock availability, order processing, delivery timelines, storage requirements, expiry management, and applicable return policies.
Ask which product literature, visual aids, and other promotional resources are included in the franchise arrangement. Ensure that all promotional claims comply with applicable regulations.
Check the contractual terms, regulatory responsibilities, payment conditions, territory restrictions, and termination provisions. Seek qualified professional advice if needed.
Moruf Lifesciences is a pharmaceutical company based in Zirakpur, Punjab, focused on gynaecology and women's healthcare.
Its published catalogue covers multiple categories, including iron and folic acid supplements, pregnancy nutrition, PCOS-related formulations, hormonal medicines, fertility-related products, menstrual-health medicines, vaginal-care products, and selected urinary healthcare products.
For entrepreneurs evaluating a Gynae PCD Pharma Franchise Company, Moruf Lifesciences is an option to consider based on its product range and franchise offering.
Prospective partners should request the latest catalogue and discuss:
Current product availability and compositions
Applicable product and manufacturing documentation
Pricing and initial order requirements
Territory availability and written monopoly terms
Promotional support
Order processing and supply arrangements
Applicable regulatory requirements
The right franchise partner is one whose portfolio and commercial terms suit the business's target market and operating capabilities.
Product categories worth evaluating include iron and folic acid supplements, pregnancy nutrition, PCOS-related formulations, progesterone products, fertility-related medicines, menstrual-health products, and selected vaginal and urinary healthcare products. Actual demand depends on the location, product, competition, and healthcare requirements.
Moruf Lifesciences lists products across multiple categories, including Corafer-FB, Corafer-XT, Ferjoy-PCO, Ferjoy-IN, Mopreg, Mytermcare, Mofert, Myletro, Nexic-M, Tinwar-CL, Wojoy Vaginal Wash, and the Morflow range. Refer to the company's current catalogue to verify product details and availability.
Start by researching the local market and comparing the available product categories. Consider product relevance, competition, pricing, documentation, supply reliability, and the commercial terms offered by the supplier. There is no single product list that guarantees sales.
Fertility medicines can form part of a gynaecology portfolio, but they have specific indications and prescribing requirements. Franchise partners should verify the applicable regulatory requirements and ensure that products are distributed and promoted appropriately.
Review the product catalogue, applicable quality and manufacturing documentation, pricing, supply arrangements, promotional support, franchise territory, and written agreement. Confirm all relevant details directly with the company.
Moruf Lifesciences describes monopoly-based franchise opportunities as part of its offering. Availability and the scope of the rights should be confirmed directly with the company for the intended territory and product range.
Confirm the current product details, approved indications, documentation, availability, pricing, and applicable storage and distribution requirements. Compare these details with local market needs before placing an order.
The gynae products worth evaluating for a PCD pharma franchise business in India span several categories, from iron and folic acid supplements to pregnancy nutrition, PCOS-related formulations, hormonal medicines, fertility-related products, menstrual-health medicines, and selected vaginal and urinary healthcare products.
Rather than assuming that a particular product is guaranteed to sell, franchise partners should compare product documentation, availability, pricing, local requirements, and supplier reliability.
Moruf Lifesciences offers a broad women's healthcare catalogue that entrepreneurs can review when searching for a PCD Pharma Franchise Company specialising in gynaecology.
Explore the current product range, verify the relevant documentation, and contact Moruf Lifesciences to discuss franchise availability and commercial terms.
Disclaimer: This article is for general business information and is not medical advice. Product compositions and availability may change; verify current details against official product documentation. Prescription medicines must be used only under appropriate professional supervision.
Name – Moruf Lifesciences
Phone Numbers – +91-9888163636
Email - moruflifesciences0719@gmail.com
Address: SCO 5-6, Wadhawa Nagar, Near Hotel Sunpark
Kalka Highway, Zirakpur, Punjab, India – 140603
Read more at -
Top 7 Gynae PCD Pharma Franchise in India
Gynae PCD Pharma Franchise With Monopoly Rights Benefits
Gynae PCD Pharma Franchise: Investment, and Business Scope
How to Choose the Best Gynae PCD Pharma Franchise Company
Rising Growth of India’s Healthcare Industry
call us
whatsapp
contact us